Amrutanjan Health Care Ltd Share Price Today

Amrutanjan Health Care Ltd. Share Price

Overview

Amrutanjan Health Care Ltd. share price is currently ₹500.50, up by ₹3.96 (0.8%) from its previous closing price of ₹496.54. The share price has gained 1.46% over the past month and declined -29.05% over the past year. The stock's 52-week low and high are ₹469.42 and ₹744.41, respectively. Amrutanjan Health Care Ltd. has a market capitalisation of ₹ 1,480.00 Cr. The share price was last updated on 09 Oct 2026, 03:50 PM IST.

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 290% at ₹2.9/Share	11-Sep-2026	11-Sep-2026
DividendsInterim Dividend of 100% at ₹1/Share	06-Feb-2026	07-Feb-2026
DividendsInterim Dividend of 100% at ₹1/Share	18-Nov-2025	18-Nov-2025
DividendsFinal Dividend of 260% at ₹2.6/Share	16-Sep-2025	16-Sep-2025

Actions

Ex-Date

Record-Date

DividendsFinal Dividend of 290% at ₹2.9/Share

11-Sep-2026

DividendsInterim Dividend of 100% at ₹1/Share

06-Feb-2026

07-Feb-2026

DividendsInterim Dividend of 100% at ₹1/Share

18-Nov-2025

DividendsFinal Dividend of 260% at ₹2.6/Share

16-Sep-2025

Mutual Fund Holder	Aug 26 Shares held	Sep 26 Shares held
ICICI Prudential Conservative Hybrid Fund - Regular Plan - Growth	62.75 k	62.75 k no change
iSIF Equity Long-Short Fund - Regular Plan - Growth	1.80 Lac	- (100%)
ICICI Prudential Quant Fund - Growth	46.12 k	- (100%)
ICICI Prudential FMCG Fund - Growth	6.60 Lac	- (100%)
ICICI Prudential Balanced Hybrid Fund - Regular Plan - Growth	52.61 k	- (100%)

Mutual Fund Holder

Aug 26

Shares held

Sep 26

Shares held

ICICI Prudential Conservative Hybrid Fund - Regular Plan - Growth

62.75 k

no change

iSIF Equity Long-Short Fund - Regular Plan - Growth

1.80 Lac

(100%)

ICICI Prudential Quant Fund - Growth

46.12 k

(100%)

ICICI Prudential FMCG Fund - Growth

6.60 Lac

(100%)

ICICI Prudential Balanced Hybrid Fund - Regular Plan - Growth

52.61 k

(100%)

Tejaswi

15 Sep • 6:20 AM · SEBI-Registered Analyst

Amrutanjan Healthcare: Strong Moat, Weak Momentum?

AMRUTANJAN

Amrutanjan Health Care is a consumer-healthcare business with a strong balance sheet. Its century-old balm brand, low debt and high return on capital make it interesting for shareholders. But the latest numbers show that the core business is slowing, while a large new investment is yet to prove its value. The company has made its ayurvedic pain balm since 1893. In FY26, sales rose 11% to ₹503 crore, while net profit was ₹58 crore. ROCE stood at 25%, roughly twice the industry median. Borrowings were only ₹2 crore against reserves of ₹367 crore. The biggest strategic move is a ₹150crore greenfield sanitary-napkin plant in Telangana. Women’s hygiene sales rose 27% to ₹36.36 crore in Q1 FY27. However, the core OTC business is the concern for investors seeking steady growth. OTC sales were ₹57.26 crore in Q1 FY27, growing just 0.5%. Overall quarterly sales increased 9.5% to ₹102.97 crore, but operating margin fell to 6.1% from 9.0%. Profit after tax dropped 47.7% to ₹4.37 crore, partly due to a one-time lease-rent impact. The stock had fallen about 35% over a year and traded at around 23 times earnings, below its industry and historical averages. The correction offers some comfort, especially with a sound balance sheet and FY26 dividend of ₹4.90 per share. Yet the ₹150crore capex creates execution risk. Free cash flow turned negative by ₹19 crore in FY26, and the new plant must generate adequate returns. If Comfy scales and core brands recover, shareholders could benefit from operating leverage and a valuation re-rating. If balm growth remains weak, the investment may depress returns. Overall, Amrutanjan is financially sound, but not a straightforward growth story. The opportunity is real, but shareholders should watch margins, cash flow, plant utilisation and whether new capacity earns attractive returns before expecting strong returns.!

SASI KUMAR SEBI RA

10 Sep • 9:22 PM · SEBI-Registered Analyst

Dividend stocks for tomorrow | Sept 11 .

1. HeidelbergCement India - ₹7 2. Alphageo India - ₹5 3. Balmer Lawrie - ₹4.25 4. Amrutanjan Health - ₹2.90 5. GSFC - ₹5 6. Talbros Auto - ₹0.55 7. Emkay Tools - ₹3 8. Arihant Academy - ₹2 9. Krystal Integrated - ₹1.5 . . . .

Pradeep Carpenter

20 Apr • 9:01 AM · SEBI-Registered Analyst

Morning Market Views:

Nifty has been in the strong momentum from past few sessions and is looking good on the charts with strong support placed around 24000 on the lower side. The immediate resistance for the index is around 24500-24700 on the upper side. The overall trend of the index is Buy on dips for the near term till the index is holding above 24000 on closing basis. Bank Nifty have given good bounce in the recent past above 55500 on the daily charts. The overall trend of the index is good with some volatility expected today after the recent brutal strong up move on the daily charts. The sentiment on the street will remain bullish with support for the index placed around 55000 while 56500 remains resistance for the day. Stocks In News Amrutanjan Health: The company has announced its strategic entry into the personal care segment with the launch of its new razors category. Marsons: The company has successfully secured an order or funding worth Rs. 15 crore from Inox Solar. Shyam Metalics: The Enforcement Directorate (ED) has attached investments worth Rs. 152 crore belonging to the company's arm, Eastern Coalfields, in connection with an ongoing PMLA case. Onix Solar Energy: The company's board has approved a proposal to raise up to Rs. 130 crore in capital through a rights issue.

CIPLA

: The company received 2 Form 483 observations from the US FDA following a routine inspection of its Goa manufacturing facility conducted between April 6 and April 17. PC Jeweller: The company continues its deleveraging efforts, reducing its outstanding bank debt by another 10%, which brings its total debt repayment to over 90% of the outstanding amount.

LUPIN

: The company has expanded its Southeast Asian footprint by incorporating a new subsidiary in Thailand with a registered capital of 3 million Baht.

TRENT

: The company's board is scheduled to meet on April 22 to deliberate on a potential bonus issue and explore fundraising options through equity or a rights issue.

THREETREND RESEARCH

18 Dec • 9:46 AM · SEBI-Registered Analyst

AMRUTANJAN

Amrutanjan Health Care Ltd – Equity Research Note Company Snapshot - Consumer health & wellness company with OTC pain management legacy. - Expanding into F&B beverages and women's hygiene. - Revenue mix: OTC Pain ~55-60%, Beverages ~30-35%, Hygiene ~8-10%. - India-focused (~95%+ revenue), debt-free, promoter holding ~39-40%. Business Model - High gross margins 55-60% from branded OTC products. - TTM EBITDA margin ~15-17% due to growth investments. - Asset-light model with pan-India distribution network. - Fixed cost leverage from advertising and sales infrastructure. Growth Drivers - Double-digit revenue CAGR targeted. - OTC portfolio extensions (sprays, roll-ons). - Comfy hygiene scale-up via distribution and digital. - Fruitnik relaunch and SKU optimisation. - Margin recovery post ad-spend stabilisation. Competitive Edge - Strong 2/3 in OTC pain relief vs Iodex, Moov. - 130+ year brand trust, strong chemist penetration. - High recall in South & East India markets. Financial Snapshot (TTM/FY26) - Revenue CAGR ~10-12%, ROCE ~22-25%. - Net debt nil, positive FCF post ad-spend. - Current valuation: EV/EBITDA ~22-24x, P/E ~30-32x. Scenario Analysis (FY27E) - Base: 11% revenue growth, 18% EBITDA margin → 12-15% upside. - Bull: 14% growth, 21% margin → 30-35% upside. - Bear: 7% growth, 15% margin → 18-22% downside. Investment View - Steady consumer health compounder with high ROCE. - Re-rating needs EBITDA >20% and Comfy scale. - Suitable for long-term, low-volatility portfolios.

Sohrab Shaikh (SEBI RA)

17 Feb • 10:56 PM · SEBI-Registered Analyst

Ex Dividend date on 18.02.2025

1. Amrutanjan Health Rs. 1 per share 2. Bharat Forge Rs. 2.5 per share 3. Carborundum Universal Rs. 1.5 per share 4. Fieotex Chemical Rs. 0.4 per share 5. Gillette India Rs. 65 per share 6. Greenpanel Rs. 0.3 per share 7. Hindustan Aeronautics Rs. 25 per share 8. Honda India Power Rs. 10 per share 9. Natco Pharma Rs. 1.5 per share 10. NBCC Rs. 0.53 per share

BHARATFORG

HAL

NATCOPHARM

Sohrab Shaikh (SEBI RA)

20 Nov • 10:32 PM · SEBI-Registered Analyst

Companies having Ex Dividend date on 22-11-2014

1. Amrutanjan Health Care Rs. 1 per shares 2. Dhruv Consultancy Services Rs. 0.1 per share 3. FDC Rs. 5 per share 4. Krishna Defence Rs. 0.5 per share 5. Mawana Sugars Rs. 3 per share 6. MSTC Rs. 4 per share 7. Nile Rs. 4 per share 8. Orient Technologies Rs. 1.8 per share 9. Panama Petrochem Rs. 2 per share 10. Satia Industries Rs. 0.1 per share 11. Premco Global Rs. 39 per share 12. Steelcast Rs. 1.35 per share 13. Veedol Corporation Rs. 20 per share

Amrutanjan Health Care Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Amrutanjan Health Care Ltd. 👋

Expert Opinions

Frequently Asked Questions

What is the share price of Amrutanjan Health Care Ltd.?

What is the market cap of Amrutanjan Health Care Ltd.?

Should I buy Amrutanjan Health Care Ltd. stock now?

What is the 52 week high and low of Amrutanjan Health Care Ltd.?

Is the Amrutanjan Health Care Ltd. stock good to buy?

Is Amrutanjan Health Care Ltd. a good buy for the long term?

Is Amrutanjan Health Care Ltd. overvalued or undervalued?

What is the PE and PB ratio of Amrutanjan Health Care Ltd.?